Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

ABSTRACT: The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

PROVIDER: PRJNA939213 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

| PRJNA940412 | ENA

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

| PRJNA940419 | ENA

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

Project description:This study comprehensively evaluated the landscape of genetic and epigenetic events that predispose to synchronous bilateral Wilms tumor (BWT). We performed whole exome or whole genome sequencing, total-strand RNA-seq, and DNA methylation analysis using germline and/or tumor samples from 68 patients with BWT from St. Jude Children’s Research Hospital and the Children’s Oncology Group.

2023-11-10 | GSE226478 | GEO

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

2023-11-10 | GSE226234 | GEO

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-11-09 | GSE226480 | GEO

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.

Project description:Developing synchronous bilateral Wilms tumor suggests an underlying (epi)genetic predisposition. Here, we evaluate this predisposition in 68 patients using whole exome or genome sequencing (n = 85 tumors from 61 patients with matched germline blood DNA), RNA-seq (n = 99 tumors), and DNA methylation analysis (n = 61 peripheral blood, n = 29 non-diseased kidney, n = 99 tumors). We determine the predominant events for bilateral Wilms tumor predisposition: 1)pre-zygotic germline genetic variants readily detectable in blood DNA [WT1 (14.8%), NYNRIN (6.6%), TRIM28 (5%), and BRCA-related genes (5%)] or 2)post-zygotic epigenetic hypermethylation at 11p15.5 H19/ICR1 that may require analysis of multiple tissue types for diagnosis. Of 99 total tumor specimens, 16 (16.1%) have 11p15.5 normal retention of imprinting, 25 (25.2%) have 11p15.5 copy neutral loss of heterozygosity, and 58 (58.6%) have 11p15.5 H19/ICR1 epigenetic hypermethylation (loss of imprinting). Here, we ascertain the epigenetic and genetic modes of bilateral Wilms tumor predisposition.

| S-EPMC10728430 | biostudies-literature

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

| PRJNA943166 | ENA

Germline Variant in Ctcf Links Mental Retardation to Wilms Tumor Predisposition

Project description:SNP arrays was combined with next generation sequencing (NGS) to identify an LOH in 16q together with an unreported CTCF missense variant in its zinc finger domain. CTCF is within 16q LOH. We found that germline heterozygous variant I446K became homozygous in the tumor due to a loss of heterozygosity rearrangement affecting the whole q arm on chromosome 16. Based on CTCF role in regulating the epigenetic architechture of the genome, our findings reveal CTCF variant I446K as a link between MRD21 and Wilms tumor predisposition.

2022-01-11 | GSE193233 | GEO

Germline Variant in *Ctcf* Links Mental Retardation to Wilms Tumor Predisposition

Project description:Germline Variant in *Ctcf* Links Mental Retardation to Wilms Tumor Predisposition

| PRJNA795462 | ENA

Germline Variant in Ctcf Links Mental Retardation to Wilms Tumor Predisposition

Project description:Germline Variant in Ctcf Links Mental Retardation to Wilms Tumor Predisposition

| PRJNA795463 | ENA